References
1. Khng, Cgyw, Ey Yap, Kg Au-Eong, Th Lim, and Kh Leong. “Central Serous Retinopathy Complicating Systemic Lupus Erythematosus a Case Series.” Clinical and Experimental Ophthalmology 28.4 (2000): 309-13.
2. M.B Eckstein, D.J Spalton and G.E Holder, Visual loss from central serous retinopathy in systemic lupus erythematosus. Br. J. Ophthalmol., 77 (1993), pp. 607-609.
3. Cynthia A Carvalho-Recchia, Lawrence A Yannuzzi, Silvana Negrão, Richard F Spaide, K.Bailey Freund, Hanna Rodriguez-Coleman, Marcio Lenharo, Tomohiro lida, Corticosteroids and central serous chorioretinopathy, Ophthalmology, Volume 109, Issue 10, October 2002, Pages 1834-1837.
4. Gemenetzi, M., G. De Salvo, and A. J. Lotery. “Central Serous Chorioretinopathy: an Update on Pathogenesis and Treatment.” Eye (2010).
5. Gass JDM. Acute Zonal Occult Outer Retinopathy. Journal of Clinical Neuro-ophthalmology 1993; 13(2): 79-97.
6. Koenekoop R.K., Racine J., Al Humaid S., Sui H., Traboulsi E., Sallum J., Saperstein D.A. (2011, May). Oral Synthetic cis-Retinoid Therapy in Subjects with Leber Congenital Amaurosis (LCA) due to Lecithin: Retinol Acyltransferase (LRAT) or Retinal Pigment Epithelial 65 Protein (RPE65) Mutations: Preliminary Results of a Phase Ib Open-Label Trial. Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO), Ft. Lauderdale, Florida.